2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC1020
Submitter : Ms. Megan Gallagher Date & Time: 10/27/2005 10:10:34
Organization : Ms. Megan Gallagher
Category : Individual Consumer
Issue Areas/Comments
The delays that continue to prevent emergency contraception from being sold over the counter are a shameful example of politics overruling science. EC is not merely a political soapbox; its availability, or lack thereof, has concrete and crucial effects on women's lives. The wrangling that has taken place to yet again delay its availability is obvious and embarassing; the reasons offered for the delay are laughable. Women have the right to a medically safe contraceptive and EC is just that.